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Abstract
Background: In humans, mutations in the enzyme glycyl-tRNA synthetase (GARS) cause motor and sensory axon loss in the
peripheral nervous system, and clinical phenotypes ranging from Charcot-Marie-Tooth neuropathy to a severe infantile form
of spinal muscular atrophy. GARS is ubiquitously expressed and may have functions in addition to its canonical role in
protein synthesis through catalyzing the addition of glycine to cognate tRNAs.
Methodology/Principal Findings: We have recently described a new mouse model with a point mutation in the Gars gene
resulting in a cysteine to arginine change at residue 201. Heterozygous GarsC201R/+ mice have locomotor and sensory
deficits. In an investigation of genetic mutations that lead to death of motor and sensory neurons, we have crossed the
GarsC201R/+ mice to two other mutants: the TgSOD1G93A model of human amyotrophic lateral sclerosis and the Legs at odd
angles mouse (Dync1h1Loa) which has a defect in the heavy chain of the dynein complex. We found the Dync1h1Loa/+;
GarsC201R/+ double heterozygous mice are more impaired than either parent, and this is may be an additive effect of both
mutations. Surprisingly, the GarsC201R mutation significantly delayed disease onset in the SOD1G93A;GarsC201R/+ double
heterozygous mutant mice and increased lifespan by 29% on the genetic background investigated.
Conclusions/Significance: These findings raise intriguing possibilities for the study of pathogenetic mechanisms in all three
mouse mutant strains.
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Introduction
Disorders that affect motor and/or sensory neurons are
relatively common and have a range of severity of symptoms,
although all include muscle weakness or paralysis to variable
extents. Such disorders include hereditary motor and sensory
neuropathies (the Charcot-Marie-Tooth, CMT, diseases), which
are the most frequent genetic disorders of the peripheral nervous
system, affecting up to 1 in 2,500 people [1]. Diseases affecting
solely or primarily motor neurons include motor neuron diseases
(MNDs) such as amyotrophic lateral sclerosis (ALS); currently,
death certificates of ,1/400 people in England and Wales give
‘cause of death’ as forms of MND (J. Stevens pers.comm., [2]) and
each year, 5000 Americans are diagnosed with ALS, 10% of
whom are,40 years old [3].
Several mutant genes are known to cause sensory and/or
motor neuron degeneration in humans and mice and other
model organisms. In ALS, ,10% of cases are familial (FALS),
usually autosomal dominant and mutations in the ubiquitously
expressed enzyme superoxide dismutase 1 (SOD1), are causal
in,25% of FALS [4,5] and in ,3% of sporadic ALS (SALS).
Mutant SOD1 takes on a toxic gain of unknown function.
Several other genes with less common mutations have also been
described in ALS and in the other motor neuron diseases, and
mutations in these proteins have consistently implicated such
cellular processes as axonal transport, RNA processing and
mitochondrial function in the dysfunction of human motor and/
or sensory neurons (see recent Reviews of MND and inherited
neuropathy genetics [2,6–12]).
With respect to axonal transport, mutations in protein subunits
of the dynein-dynactin complexes, which are responsible for
retrograde trafficking in axons, give rise to sensory and/or motor
neuron degeneration with relatively mild symptoms and a slow
onset. For example, mutations in the p150 subunit of dynactin
cause a slowly progressive form of lower motor neuron disease
without sensory symptoms [13].
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Recently a new class of proteins, tRNA-synthetases has also
been shown to be causative for motor and/or sensory neuronal
dysfunction. Mutations in glycyl-tRNA synthetase (GARS) give rise
to a range of clinical conditions generally resulting in slowly
progressing muscle weakness and atrophy, with focal wasting of
the musculature; the disease spectrum ranges from Charcot-
Marie-Tooth type 2D (CMT2D) to severe distal spinal muscular
atrophy type V (dSMA V/HMN V) [14–18].
Although different genetic mutations trigger disease in each
disorder, it is possible that ultimately at least some of these motor/
sensory neuronal diseases share certain downstream pathways that
lead to neuron dysfunction and degeneration, because there may be
limited numbers of ways in which neurons – particularly those with
long axons - can respond to genetic or environmental insult.
We are working with a set of mouse mutants that model different
types of sensory and motor neuron disease (see Table 1 for summary).
We have undertaken crosses of different mutants to look for genetic
interactions that may not otherwise be obvious, but which may
inform us of the pathogenetic mechanisms of these disorders, which
currently remain more or less unknown in every case.
The first mouse we are working with, the TgSOD1G93A
transgenic (SOD1G93A), models human amyotrophic lateral
sclerosis (ALS) [19]. This mouse is widely used and carries a
human mutant transgene array with a glycine to alanine mutation
at residue 93 of SOD1, which is causative for ALS in humans, and
which results in a similar phenotype in the mice who succumb to
endstage disease at ,130 d of age (depending on genetic
background)[19].
The second mouse we are characterizing is the Legs at odd
angles mouse (Dync1h1Loa) which does not model a specific
human disease, but the mice are of interest because heterozygotes
have a mild motor deficit and a pronounced loss of proprioceptive
neurons arising from a point mutation in the heavy chain gene
(Dync1h1) of the cytoplasmic dynein complex [20–24].
The third mouse of interest is a new model we have recently
described [25], which carries a point mutation leading to a non-
conservative amino acid change in the glycine t-RNA synthetase
gene (Gars). The new mouse model, GarsC201R, has a cysteine to
arginine change at position 201, which, in heterozygous animals,
results in deficits in grip strength, decreased motor flexibility,
disruption of fine motor control, as well as a reduction in axon
diameter in peripheral nerves and alterations in nerve conduction
with neuromuscular junction deficits; this phenotype is variable
depending on genetic background [25].
SOD1, Dync1h and Gars are ubiquitously expressed genes and
their protein products are essential for all cell types. However,
mutations in these genes specifically affect sensory and/or motor
neuron function. The mechanistic links between aberrant protein
and pathological mechanism, and cell type specificity, remain
unclear for all three mutations. As part of an investigation of our
mouse models, we have undertaken a classic genetic approach:
crossing the mutants in different combinations to determine if we
can detect an interaction between these proteins, which may lead
us to new pathways of pathogenesis. We and others have already
reported on the results of a Dync1h1Loa/+ x SOD1G93A cross: the
double heterozygous progeny, Dync1h1Loa/+;SOD1G93A have an
intriguing delayed disease onset compared to their SOD1G93A
hemizygous littermates and parents, and an extended lifespan
reported to be between 9% and 28% [20,21,23,26]. Here we
report our results from assessing the progeny of the two other
Table 1. Phenotype summary for hemizygous SOD1G93A transgenic mice, heterozygous Dync1h1Loa/+ and GarsC201R/+ mouse
strains.
Mouse strain SOD1G93A Dync1h1Loa GarsC201R
Type of mutation Transgenic overexpressor of human
mutant superoxide dismutase 1 gene
ENU induced point mutation in
endogenous mouse cytoplasmic dynein
heavy chain 1 gene, resulting in missense
mutation in protein, phenylalanine to
tyrosine at residue 580
ENU induced point mutation in endogenous
mouse glycyl-RNA synthetase gene, resulting
in missense mutation in protein, cysteine to
arginine at residue 201
Primary reference [19] [22] [25]
Genetic data Autosomal dominant trait; transgene
inserted into mouse chromosome
12 [27]
Autosomal dominant mutation on mouse
chromosome 12
Autosomal dominant mutation on mouse
chromosome 6
Human disease model Amyotrophic lateral sclerosis None described Charcot-Marie-Tooth type 2D (some features)
Breeding Females are infertile; equal numbers
of male and female progeny are
produced
Males and females are fully fertile; equal
numbers of male and female progeny are
produced
Males and females are fully fertile; equal
numbers of male and female progeny are
produced
Lifespan ,130 days for humane endpoint,
depending on genetic background
Over 2 years Over 2 years
Age at onset ,90 days depending on genetic
background
1–3 months depending on genetic
background
At least 1 month depending on genetic
background
Symptoms at onset Paralysis and weight loss Limb clasping when suspended by the
tail; low based gait in some mice
Mild deficits in grip strength and fine motor
control
Nerve and muscle Motor neuron degeneration, loss
of muscle force, muscle atrophy
Mild motor neuron loss; pronounced loss
of prioprioceptors, some loss of muscle
force, no obvious muscle pathology so far
Reduction in axon diameter of peripheral
nerves, alteration in sensory nerve conduction,
neuromuscular junction deficits; some loss of
muscle force, changes in muscle fiber type
Mouse crosses Crossed to Dync1h1Loa [26]; crossed
to GarsC201R this paper
Crossed to GarsC201R this paper; crossed
to SOD1G93A [26]
Crossed to SOD1G93A this paper; crossed to
Dync1h1Loa this paper
Note that the phenotype of homozygous Dync1h1Loa/+ and GarsC201R/+ mice is considerably more severe and few homozygous animals of either strain survive much
beyond birth. Mice with two copies of the SOD1G93A transgene array are not viable.
doi:10.1371/journal.pone.0006218.t001
Gars Cross to SOD1G93A and Loa
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possible crosses: GarsC201R/+ x SOD1G93A and GarsC201R/+ x
Dync1h1Loa/+. We find Dync1h1Loa/+;GarsC201R/+ double heterozy-
gote progeny have a more severe phenotype than their mildly
affected parents, although this may simply be a manifestation of
additive effects. However, in contrast SOD1G93A;GarsC201R/+
double heterozygotes have an extension of lifespan and preserva-
tion of motor neurons which is similar to that of Dync1h1Loa/+;
SOD1G93A double heterozygotes. The results of these mouse crosses
may help inform us further of novel protein interactions and
therefore the mechanism of both SOD1G93A toxicity, and the effect
of the GarsC201R mutation.
Results
Analysis of double heterozygous progeny from a
SOD1G93A x GarsC201R/+ cross
The SOD1G93A males for this cross were on an SJL x C57BL/6
background (see Materials and Methods). Onset of motor neuron
disease symptoms (determined by start of weight loss) typically
begins at ,110 days in this colony with mice reaching disease
endpoint (defined as loss of righting reflex for 20 secs or weight loss
of 15%) at ,130 days. The GarsC201R/+ females for this cross came
from a colony in which the mutation is maintained by
backcrossing to C57BL/6J mice. SOD1G93A hemizygous females
are infertile hence we could not carry out the reciprocal SOD1G93A
female x GarsC201R/+ male cross.
GarsC201R/+ heterozygous females (n = 14, N1-4 on the C57BL/
6 background) were crossed with SOD1G93A males to produce the
expected four genetically distinct groups of littermates: wildtype 26
males and 22 females (total 48); SOD1G93A 19 males and 19 females
(total 38); GarsC201R/+ 15 males and 21 females (total 36);
SOD1G93A;GarsC201R/+ 15 males and 18 females (total 33). Thus
there was some deviation from the expected Mendelian ratio of
25% per genotype although this difference was not statistically
significant; there was no gender bias. The GarsC201R mutation lies
on mouse chromosome 6 [25] and the SOD1G93A transgene array
lies on mouse chromosome 12 [27], thus the two loci are
segregating independently.
Extended lifespan in SOD1G93A;GarsC201R/+ double
heterozygotes
We examined whether the mutation in glycine tRNA synthetase
inherited from the GarsC201R/+ parents, altered the lifespan of
SOD1G93A mice by comparing all four genotypes of progeny mice
(Figure 1A,B). Wildtype and GarsC201R/+ mice had a normal
lifespan and SOD1G93A progeny a significantly reduced lifespan of
12663 days for males (n = 13) and 13162 days females (n = 11),
with disease end-stage defined as above. Surprisingly, SOD1G93A;-
GarsC201R/+ double heterozygote males lived for 16364 days
(n = 10) and females lived for 17063 days (n = 10). These mice had
an increase of lifespan of 37 days for males and 39 days for females
compared to SOD1G93A littermates, averaging to approximately
29% for both sexes.
Body weight was assessed weekly and as can be seen in
Figure 1C,D, the maximum body weights of all three mutant
genotypes were lighter than their wildtype littermates and male
mice were generally 20% heavier than their female counterparts,
on the genetic backgrounds studied.
The SOD1G93A transgene array is known to delete occasionally,
which results in an extension of lifespan of the mice because the
severity of the phenotype depends on the level of mutant SOD1
protein expression. While it is extremely unlikely that the
extension of lifespan seen in all 20 SOD1G93A;GarsC201R/+ double
heterozygotes was caused by deletion in the transgene array in
mice with this genotype only, nevertheless we quantified the level
of SOD1 protein expression in the four progeny genotypes. Spinal
cords from 4 month old wildtype, SOD1G93A hemizygote,
GarsC201R/+ heterozygote and SOD1G93A;GarsC201R/+ double het-
erozygotes were homogenized and western blots of these
homogenates were probed with Novocastra NCL-SOD1 antibody,
which detects both human and mouse SOD1 [26]. The membrane
was reprobed with anti b2actin as an internal protein loading
control and signals were quantified as described in Materials and
Methods. We found human SOD1 was present in SOD1G93A
hemizygotes, and SOD1G93A;GarsC201R/+ double heterozygotes only
(Figure 1E). When the blots were quantified we found no
significant differences in human SOD1 protein levels between
SOD1G93A hemizygotes (24.763.3 arbitrary units), and SOD1G93A;-
GarsC201R/+ double heterozygotes (23.861.9 arbitrary units)
(Figure 1F), indicating the extended lifespan of double heterozy-
gotes was not the result of a deletion in the SOD1G93A transgene
array (n = 4 for all cohorts).
Disease characteristics in SOD1G93A;GarsC201R/+ progeny
Disease phenotype and progression in each of the 4 littermate
cohorts were also examined by in vivo physiological analysis of the
hindlimb muscles, tibialis anterior (TA) and extensor digitorum
longus (EDL) in 120 d old female mice. For each genotype cohort,
n = 5 unless otherwise stated.
Both twitch and tetanic muscle force were assessed. As can be
seen in Figures 2A and B, TA muscles in SOD1G93A mice were
significantly weaker than the corresponding muscles in their
wildtype littermates. Whereas TA muscles in wildtype mice had a
maximum twitch and tetanic force of 40.261.2 g. and
131.562.3 g respectively, in SOD1G93A littermates, twitch force
was reduced to only 11.261.6 g (P#0.001) and tetanic force was
only 28.664.0 g (P= 0.009).
In GarsC201R/+ mice, there was also a reduction in force of TA
muscles, so that twitch and tetanic tension was 19.561.2 g and
68.063.7 g, respectively, which is significantly less than that of
their wildtype littermates (P#0.001). In SOD1G93A;GarsC201R/+
double heterozygotes, the comparable TA maximum twitch force
was 16.861.1 g, and the maximum tetanic force was 49.964.1 g,
which is significantly weaker than the corresponding values in
wildtype mice (P= 0.037 and P=0.009 respectively). However,
although the TA muscles in the double heterozygote, SOD1G93A;-
GarsC201R/+ mice were markedly weaker than wildtype littermates,
they were significantly stronger than TA muscles in SOD1G93A
mice (i.e. twitch force: 16.861.1 g compared to 11.261.6 g
(P#0.001); tetanic force: 49.964.1 g compared to 28.664.0 g
(P= 0.009)).
The TA muscles from all 4 genotypes were removed and
weighed at the end of the physiological tests. The weakness
observed in TA muscles of SOD1G93A, GarsC201R/+ and SOD1G93A;-
GarsC201R/+ double heterozygotes was reflected in a significant
reduction in the weight of these muscles compared to those of
wildtype littermates (Figure 2C; P#0.001).
We also examined the force characteristics of the EDL muscles
in each genotype cohort. As observed in TA, EDL muscles of
SOD1G93A and GarsC201R mice were significantly weaker than EDL
in wildtype littermates (see Figure S1A and B, Supplementary
Table S1). In contrast to the findings for TA, there was no
significant difference (i.e. improvement) in the force output of EDL
in SOD1G93A;GarsC201R/+ double heterozygotes compared to their
SOD1G93A littermates. Further analysis of the contraction charac-
teristics of EDL in the SOD1G93A;GarsC201R/+ double heterozygotes
also established that there was no difference in these characteristics
from those in EDL of SOD1G93A or GarsC201R/+ heterozygotes, so
Gars Cross to SOD1G93A and Loa
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Figure 1. Lifespan of littermates from the SOD1G93A x GarsC201R/+ cross. (A) Male mice: SOD1G93A n= 13; SOD1G93A;GarsC201R/+ n= 10. (B) Female
mice: SOD1G93A n= 11; SOD1G93A;GarsC201R/+ n= 10. Maximum body weights. Weights were recorded between 90 and 110 days which corresponds to
the maximum body weight prior to weight loss as the disease progresses. (C) Males: wildtype 30.260.9 g (n = 13); SOD1G93A 25.160.4 g (n = 13);
GarsC201R/+ 27.960.4 g (n = 12); SOD1G93A;GarsC201R/+ 24.960.6 g (n = 11). (D) Females: wildtype 22.660.4 g (n = 13); SOD1G93A 19.560.6 g (n = 12);
GarsC201R/+ 20.360.3 g (n = 9); SOD1G93A;GarsC201R/+ 20.260.5 g (n = 11). (E) A representative western blot of human and mouse SOD1 using spinal
cord homogenate from 4 month old mice; hSOD is human SOD1 protein. (F) Quantification of the human SOD1 protein levels in shows no transgene
loss in SOD1G93A;GarsC201R/+ compared to SOD1G93A mice mice (n = 4 per cohort).
doi:10.1371/journal.pone.0006218.g001
Gars Cross to SOD1G93A and Loa
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Figure 2. Muscle force and phenotype in TA muscles from littermates of the SOD1G93A x GarsC201R/+ cross at 120 days of age. The bar
charts show: (A) the maximum twitch and, (B) tetanic force generated by TA muscles and, (C) the mean weight of TA muscles from each genotype. (D)
shows examples of TA muscle sections stained for succinate dehydrogenase (SDH), an indicator of oxidative capacity. Scale bar = 70 mm. (E) From
sections such as these the cross sectional area (CSA) of TA muscle fibers in SDH stained sections was assessed and the mean CSA is shown in the bar
chart (n = 3 per genotype). (F) The distribution of muscle fiber area is shown in the frequency distribution histogram (n= 5 per genotype). Errors bars
represent SEM (not visable in C).
doi:10.1371/journal.pone.0006218.g002
Gars Cross to SOD1G93A and Loa
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that time to peak, half relaxation time and the fatigue index of
EDL muscles were similar in all genotype cohorts (Supplementary
Table S2).
We also assessed the number of motor units that innervated the
hindlimb muscles of mice of each genotype. TA is normally
innervated by a very large number of motor units so that a reliable
assessment of motor unit number in TA is not possible using the
method of motor unit (MU) estimation employed in this study.
Therefore, despite the absence of significant differences in EDL
muscle force characteristics and since motor unit changes are not
always immediately reflected in alterations in muscle phenotype,
we assessed the number of functional motor units that innervated
EDL muscles of mice of each genotype. Typical examples of motor
unit traces from EDL muscles of mice of each genotype are shown
in Figure 3A, and the mean number of surviving motor units in
each experimental group (n= 5 for each genotype) is summarized
in the bar chart (Figure 3B). In EDL muscles of SOD1G93A mice,
there is a significant reduction in the number of surviving motor
units at 120 d compared to wildtype littermates. Thus, in wildtype
mice, EDL is innervated by 3661 motor units but in SOD1G93A
mice, only 1461 motor units survive. There is no loss of motor
units in GarsC201R/+ mice, and 3861 motor units survive.
However, in SOD1G93A;GarsC201R/+ double heterozygotes, there
was a surprising and significant increase in motor unit survival
compared to SOD1G93A mice, so that 3161 motor units survive
(P#0.001).
Following completion of the in vivo physiological analysis of
muscle function and motor unit survival, the TA muscles and
spinal cords of each animal were removed for histological analysis.
TA muscle is normally a fast-contracting muscle that fatigues
rapidly when repeatedly stimulated. In SOD1G93A mice this
characteristic feature of TA changes dramatically and by 120
days of age TA becomes a slow, fatigue-resistant muscle. These
changes in the fatigue characteristics of TA muscles of SOD1G93A
mice are reflected in alterations in the histochemical properties of
the muscle fibers, which show an increase in oxidative capacity,
staining darkly for the oxidative enzyme succinate dehydrogenase
(SDH). We stained TA muscles for SDH activity and compared
the pattern of staining in wildtype mice to that observed in TA
muscles of SOD1G93A, GarsC201R/+ and SOD1G93A;GarsC201R/+
double heterozygote mice. As can be seen in Figure 2D, there is
a dramatic increase in the number of darkly stained fibers in TA
muscles of SOD1G93A mice, and a slight increase in the proportion
of dark fibers in TA of GarsC201R/+ mice. However, in
SOD1G93A;GarsC201R/+ double heterozygotes there was a greater
proportion of lightly stained fibers than present in SOD1G93A
muscles, although significantly more fibers were darkly stained
than in TA muscles of wildtype or GarsC201R/+ mice.
It can also be seen in Figure 2D that the size of the muscle fibers
appears to vary among the different genotypes. We therefore
assessed the cross-sectional area (CSA) of TA muscle fibers in SDH
stained sections from mice of each genotype. The bar chart in
Figure 2E summarizes the results and shows that the mean CSA of
TA muscle fibers of wildtype mice is 2292614 mm2 (n= 3), and in
SOD1G93A mice this is reduced to 1648620 mm2 (n= 3). In
contrast, there is a significant increase in the mean CSA of TA
muscle fibers in GarsC201R/+ mice to 3130628 mm2 (n= 3). In TA
muscles of GarsC201R/+;SOD1G93A double heterozygotes, the mean
CSA is 2013614 mm2 (n = 3). Thus there is a significant decrease
in the CSA of TA muscle fibers in SOD1G93A mice and a significant
increase in GarsC201R/+ mice compared to controls (P,0.001).
However, in the GarsC201R/+;SOD1G93A mice the mean CSA of TA
muscle fibers is greater than that in SOD1G93A mice, and is similar
to that observed in wildtype animals. In order to distinguish
whether these findings of mean CSA were due to a loss or gain of a
specific group of muscle fibers, we undertook a morphometric
analysis of the muscle fiber size distribution for each genotype
(Figure 2F). Our results show that in SOD1G93A mice, there are
Figure 3. Motor unit and motor neuron survival in littermates from the SOD1G93A x GarsC201R/+ cross at 120 days of age. (A) shows
examples of motor unit traces from EDL muscles of mice of each genotype. (B) The bar chart shows the mean motor unit survival in each littermate
cohort (n = 5 female littermates per genotype at 120 days of age). (C) Examples of cross sections of spinal cord from mice of each genotype showing
motor neurons within the ventral horn are shown. The sciatic motor pools are identified within the magnified inserts. Scale bars = 100 mm.The bar
chart in (D) shows the mean motor neuron survival (n = 3 per genotype). Error bars represent SEM.
doi:10.1371/journal.pone.0006218.g003
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fewer large muscle fibers present than in the wildtype TA muscle.
In GarsC201R/+ mice, there is a greater proportion of large fibers
present, and some of the fibers have a larger CSA observed in
wildtype muscles. However, in SOD1G93A;GarsC201R/+ mice, the TA
muscles have a greater proportion of large fibers than observed in
SOD1G93A mice, suggesting that the presence of the GarsC201R/+
mutation has prevented the reduction in muscle fiber area that
otherwise occurs in TA muscles of SOD1G93A mice by 120 days.
It is well established that the loss of muscle force and reduction
in motor unit survival in 120 d SOD1G93A mice is due to the
degeneration of a large number of motor neurons in the lumbar
spinal cord. To determine if the improvements in muscle function
and morphology in SOD1G93A;GarsC201R/+ were reflected in an
increase in motor neuron survival in these mice compared to their
SOD1G93A littermates, motor neuron survival was assessed in
littermates of each genotype. Examples of sections of lumbar spinal
cords from each experimental group are shown in Figure 3C and
the mean motor neuron survival is summarized in the bar chart
(Figure 3D; n= 3 per genotype). As expected, in SOD1G93A mice
there is a dramatic decrease in the number of motor neurons that
survive by 120 d and in the portion of the sciatic motor pool
examined (see methods for details) only 155610 motor neurons
survive compared to 44769 motor neurons in the same portion of
the sciatic motor pool in wildtype littermates (P,0.001). However,
in SOD1G93A;GarsC201R/+ littermates there is a significant increase
in motor neuron survival, and 263628 motor neurons survive,
which is significantly greater than in SOD1G93A littermates
(P = 0.023). In GarsC201R/+ mice there is no loss of motor neurons,
at least at this stage and 467611 motor neurons are present in the
sciatic motor pool at 120 d.
Investigating protein levels and interactions in the a
SOD1G93A x GarsC201R/+ cross
Our previous studies have shown that the levels of GARS
protein are significantly increased in GarsC201R/+ heterozygotes
compared to wildtype littermates at 15 days of age, but there is no
significant difference in GARS levels in brain by 90 days of age
[25]. To quantify GARS protein levels in the progeny of this cross,
spinal cord protein homogenates were made from wildtype,
SOD1G93A, GarsC201R/+ and SOD1G93A;GarsC201R/+ littermates at
120 days of age (n = 4 for all genotypes). GARS levels were
normalized to b2actin (an internal protein loading control) as
described previously [25]. We found no significant difference in
normalised GARS protein levels between wildtype (10.761.4
arbitrary units) and SOD1G93A (9.461.5 arbitrary units) animals.
However the GARS levels in GarsC201R/+ mice (18.561.9 arbitrary
units) and in SOD1G93A;GarsC201R/+ mice (19.262.4 arbitrary units)
were both significantly higher than that of wildtype animals
(p = 0.034 compared to GarsC201R/+ and p= 0.047 compared to
SOD1G93A;GarsC201R/+, see Supplementary Figure S2A, B). This
difference in protein levels compared to that found in [25] may
reflect the mixed genetic background segregating in the current
cross. There was no significant difference in GARS levels between
GarsC201R/+ and SOD1G93A;GarsC201R/+ mice.
Other studies have demonstrated that lysyl-tRNA synthetase
(KARS) can interact with SOD1 and this interaction is stronger
for mutant than wildtype SOD1 [28,29]. Thus we investigated if
we could detect an interaction between GARS and SOD1 in our
mice, by co-immunoprecipitation studies with all four genotypes.
Immunoprecipitation was performed upon native spinal cord
homogenates from 120 day old mice (n = 3 per cohort) using either
SOD1 or GARS antibodies linked to agarose beads to pull down
the protein of interest and any interacting proteins. The pull
downs were then probed for interacting proteins on western blots.
In these studies we could find no evidence of a GARS-SOD1
protein interaction in any of the four genotypes studied (data not
shown).
Analysis of double heterozygous progeny from a
Dync1h1Loa/+ x GarsC201R/+ cross
Dync1h1Loa/+ mice are maintained by backcrossing to C57BL/6J
mice and all mice used as parents in this cross were at least
generation N10 and are thus congenic for this background. The
GarsC201R/+ parents used in this cross were as described above i.e.
maintained by crossing to C57BL/6 but not congenic. The
Dync1h1Loa/+ mutation leads to defects in motor and sensory
neurons, but in heterozygotes the phenotype is mild and there are
no known defects in lifespan or fertility [22].
Dync1h1Loa/+ heterozygous mice (n = 4 males) were crossed with
GarsC201R/+ mice (n= 8 females, N1-4 from the C57BL/6
backcross), producing the four expected genotypes of progeny:
wildtype 25 males and 23 females (total 48); Dync1h1Loa/+ 11 males
and 11 females (total 22); GarsC201R/+ 37 males and 24 females
(total 61); Dync1h1Loa/+;GarsC201R/+ 21 males and 12 females (total
33). Thus there was some deviation from the expected Mendelian
ratio of 25% per genotype in that we see a loss of animals carrying
the Dync1h1Loa mutation, which is in accordance with our previous
findings for this mutation [22,26]. All mice were genotyped for the
GarsC201R mutation and Dync1h1Loa mutation as previously
described [22,25,26] at approximately 28 days of age. All
phenotypic characterization took place blind to genotype which
was then decoded. The dynein heavy chain gene lies on Mmu12
and thus segregates independently of the Gars locus.
Characteristics of Dync1h1Loa/+;GarsC201R/+ progeny
Mice from all four genotypes were tested for grip strength at 7
months of age and no significant difference was detected between
the GarsC201R/+ heterozygotes and sex-matched Dync1h1Loa/+;
GarsC201R/+ double heterozygotes (Supplementary Figure S3A,
B). However, starting at 4 months of age, a gait deficit was
observed that was more pronounced in the Dync1h1Loa/+;GarsC201R/+
double heterozygous animals compared to their littermates and
parents (Movie S1,Movie S2,Movie S3,Movie S4). A wire walk test
was carried out at 7 months of age to quantify this defect: in this test
mice are put on a mesh cage lid and timed as they walk for one
minute on the horizontal lid while the number of ‘foot placing
errors’ - occasions in which the mouse misses the wire mesh and puts
a forepaw or hindpaw into the hole between the wires - is counted.
The double heterozygotes performed significantly worse than their
wildtype, Dync1h1Loa/+ or GarsC201R/+ littermates (Figure 4). For
male progeny, Dync1h1Loa/+;GarsC201R/+ double heterozygotes made
1661 foot placing errors (n= 12) compared to their littermates
(wildtype 160 foot placing errors, n = 12; Dync1h1Loa/+ 461 foot
placing errors, n= 9; GarsC201R/+ 260 foot placing errors, n= 12).
Female Dync1h1Loa/+;GarsC201R/+ double heterozygotes made 1962
foot placing errors (n= 9) compared to their littermates (wildtype
260 foot placing errors, n = 11; Dync1h1Loa/+ 661 foot placing
errors, n= 11; GarsC201R/+ 361 foot placing errors, n= 10). This
novel gait deficit may represent the additive effects of both
mutations, rather than any interaction between them. We also
found that by 7 months of age the Dync1h1Loa/+;GarsC201R/+ double
heterozygotes had developed tremor – 5 out of 5 mice studied
showed continuous whole body tremors when observed on the wire
mesh of a cage lid; tremors were not seen in wildtype littermates.
In vivo physiological assessment of TA and EDL muscle force
was also performed in 9 months old animals from the Dync1h1Loa/+
x GarsC201R/+ cross (all females, n = 3 for all genotypes except for
Dync1h1Loa/+ where n= 2, Supplementary Table S3; Supplemen-
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tary Figure. S4). Wildtype littermates had a maximum tetanic
force in TA muscle of 126.262.7 g. As in the experiments
described above, TA muscles in the GarsC201R/+ mice were
significantly weaker and had a maximum tetanic force of
60.663.0 g (P = 0.002). In the double heterozygote Dync1h1Loa/+;
GarsC201R/+ mice, the maximum force was 52.667.3 g, which is
not significantly different from that observed in their GarsC201R/+
littermates (P = 0.004). The Dync1h1Loa/+ mice were slightly weaker
than their wildtype littermates, but to a lesser extent than
GarsC201R/+, so that the maximum tetanic force of TA muscles in
Dync1h1Loa/+ mice was 109.065.1 g (P= 0.01). This finding
confirms our previous results that also show that there is a small
reduction in the force of hindlimb muscles in Dync1h1Loa/+ mice
(Kieran et al, 2005). We also assessed muscle force in EDL muscles
of mice of each genotype, and found no significant difference in
the maximum muscle force or the muscle contractile character-
istics of EDL muscles from the 4 genotypes of the Dync1h1Loa/+ x
GarsC201R/+ cross (Supplementary Table S3 and Supplementary
Fig. S4).
The number of motor units innervating the EDL muscles in
mice of each genotype was also examined and the results showed
that there was no significant difference in motor unit number
between any of the experimental groups (see Supplementary
Figure S4). Together, these results indicate that the Dync1h1Loa/+
mutation does not have an additional effect on the muscle force of
the GarsC201R/+ mice since both TA and EDL muscles from the
GarsC201R/+ mice and the double heterozygote Dync1h1Loa/+;
GarsC201R/+ mice pull similar muscle forces and have a normal
complement of motor units.
Investigating protein levels and interactions in the
Dync1h1Loa/+ x GarsC201R/+ cross
Spinal cord homogenates of 4 month old mice (n= 4 for all four
genotypes) were assessed for GARS protein levels by quantitative
western blot (normalizing to b actin, as described above). We found
no significant difference in GARS protein levels between wildtype
and Dync1h1Loa/+ animals (15.061.9 and 15.862.9 arbitrary units
for wildtype and Dync1h1Loa/+ respectively). However the GARS
levels in GarsC201R/+ animals (33.161.2 arbitrary units) and in
Dync1h1Loa/+;GarsC201R/+ animals (27.061.2 arbitrary units) were
both significantly higher than that of wildtype animals (p= 0.002
compared to GarsC201R/+ and p=0.009 compared to Dync1h1Loa/+;
GarsC201R/+) (see Supplementary Figure S2C,D).
We investigated whether there was any direct interaction
between the dynein complex (which, in its native form, would
include the dynein heavy chain) and GARS by co-immunopre-
cipitation studies. Immunoprecipitation was performed upon
native spinal cord homogenates of 4 month old mice (n = 4 for
all four cohorts) using either dynein intermediate chain or GARS
antibodies linked to agarose beads to pull down the protein of
interest and any interacting proteins as described above. The pull
downs were then probed for interacting proteins on western blots.
We could find no evidence of a dynein/GARS protein interaction
in any of the four genotypes studied. In all four genotypes the
dynein intermediate chain immunoprecipitation pulled down the
dynein light chain LC8. This suggests that the dynein complex
itself is intact in all four genotypes (data not shown).
Discussion
The GarsC201R mouse is a valuable new resource both for
studying the pathogenesis of defects in this enzyme and for use as a
genetic tool to uncover interactions with cellular pathways
affecting motor and/or sensory neuronal function. We have taken
a standard genetics approach to cross this mouse strain with two
other strains that carry mutations either modelling human
neurodegenerative disease such as ALS, (SOD1G93A transgenics)
or known to have deficits that affect the motor/sensory system
(Dync1h1Loa/+ mice).
In analyzing the results of these crosses we unexpectedly found
an amelioration of the motor neuron disease phenotype caused by
the SOD1G93A transgene array in the presence of the GarsC201R/+
genotype. We and others, have previously observed a similar effect
in Dync1h1Loa/+;SOD1G93A double heterozygotes although this
finding has not yet been explained at a molecular level
[20,21,23]. Another dynein heavy chain mutant allele, Dync1h1-
Cra1/+, also extends SOD1G93A mouse lifespan [30] while a third
allele, Dync1h1Swl/+ does not [21].
Figure 4. Wirewalk footplacing errors in progeny from the Dync1h1Loa/+ x GarsC201R/+ cross at 7 months of age.Mean average numbers of
footplacing errors for each genotype. (A) Males: wildtype n= 12, Dync1h1Loa/+ n= 9, GarsC201R/+ n= 12, Dync1h1Loa/+;GarsC201R/+ n= 12. (B) Females:
wildtype n= 11, Dync1h1Loa/+ n=11, GarsC201R/+ n= 10, Dync1h1Loa/+;GarsC201R/+ n= 9. Error bars show SEM.
doi:10.1371/journal.pone.0006218.g004
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We believe the GarsC201R allele, as opposed to any other gene, is
having an effect on the SOD1G93A phenotype because (1) lifespan is
consistent between SOD1G93A hemizygous parents and progeny, (2)
the increase of lifespan only occurs in SOD1G93A hemizygotes that
also carry the GarsC201R mutation (double heterozygotes). Thus
lengthening of lifespan is consistent with GarsC201R genotype, and
not genetic background effects (although it is formally possible but
highly unlikely the effect is due to a BALB/c wildtype gene closely
linked to the Gars locus, as the original mutation was produced on a
BALB/c background [25]). We note the lifespan of SOD1G93A
hemizygotes is extended when they are bred onto a C57BL/6
background (our data and [31,32]) but again, if the lifespan
extension were due to the random segregation of C57BL/6 alleles
from the genetic background of the non-congenic GarsC201R/+
parents, we would see the same extension in SOD1G93A hemizygotes
as well as in the double heterozygotes, and this is not the case.
We did not detect any direct GARS-SOD1 protein interactions,
and therefore have to assume that the effect of the GarsC201R on the
SOD1G93A phenotype is indirect. We note that GARS is essential
for translation in all cells, and in neurons is active not only in the
cell body, but also in the periphery of cells [33]. Local translation
is essential for axon guidance, synaptic plasticity, cell migration,
cell polarity and other areas of development and maintenance of
the nervous system, and could be one phenomenon that in some
way ameliorates the effect of the SOD1G93A mutation [34–36].
We note the intriguing finding of Kunst and colleagues that lysyl-
tRNA synthetase (KARS) was one of only four proteins shown to
interact with SOD1G93A and SOD1G85R in a yeast interaction trap
experiment to find novel protein interactions with mutant SOD1
[37]. Recently, Kawamata and colleagues have shown that in
mammalian cells mutant SOD1 interacts preferentially with the
mitochondrial form of KARS [28]. These authors have also shown
KARS-SOD1 interactions occur in the mitochondria of the nervous
system in transgenic mice. In the presence of mutant SOD1, the
mitochondrial form of KARS has a high propensity to aggregate
prior to its import into mitochondria, becoming a target for
proteasome degradation, and resulting in mitochondrial dysfunc-
tion [28]. Clearly it is now of interest to look at the mitochondrial
function of GARS in light of these experiments.
Analysis of double heterozygous progeny from the Dync1h1Loa/+ x
GarsC201R/+ cross showed a significantly more pronounced phenotype
in terms of gait analysis and tremors than either parental strain, both
of which have mild phenotypes. It is difficult to tell if we are seeing
anything other than additive effects in these double heterozygote
mice, but we note that for GARS to be involved in local translation,
and possibly other non-canonical functions in the periphery of
neurons, it must be anterogradely transported. Neurons maintain a
balance of transport rates and flux in the anterograde and retrograde
direction. Both SOD1G93A transgenics and Dync1h1Loa/+ mice have
deficits in axonal transport and this is thus another phenomenon that
might affect GARS function [22,26].
Our results show the GarsC201R/+ mouse is an important
addition to the range of mouse models available for studying
neurodegenerative disease, both in directly modeling the human
GARS mutation phenotypes and for teasing out the molecular
interactions leading to pathogenesis in other neurodegenerative
disorders. We note this mouse strain is freely available for research
and we encourage its use.
Materials and Methods
Mice
The SOD1G93A parents for the cross described came from a
colony in which the transgene array is maintained by crossing
SOD1G93A hemizygous males to wildtype F1(SJL x C57BL/6)
females, as recommended by the Jackson Laboratory (hemizygous
SOD1G93A females are infertile).
Dync1h1Loa/+ mice are congenic and are maintained by
backcrossing to C57BL/6J mice. These mice are named according
to the updated nomenclature for cytoplasmic dynein subunits
[38,39].
The GarsC201R mutation arose during an ENU mutagenesis
experiment at the MRC Mammalian Genetics Unit, MRC
Harwell, UK [40] and were assessed in a full SHIRPA test
[24,41] and other tests for locomotion; we positionally cloned the
mutation and identified a T to C transition at base pair 456 that
results in a non-conservative cysteine to arginine substitution at
residue 201, as described [25]. All mice for this study were
backcrossed to C57BL/6J.
Genotyping was performed at ,40 days of age and all
phenotypic characterization was performed blind to genotype,
which was then decoded. The animal studies reported in this
paper were carried out under the guidance issued by the Medical
Research Council in Responsibility in the Use of Animals for Medical
Research (1993) and under licence from the UK Home Office.
All mice were weighed at least once a week. However, when the
SOD1G93A and SOD1G93A;GarsC201R/+ mice started to show
hindlimb weakness, these mice were weighed at least twice a week.
Genotyping SOD1G93A, Dync1h1Loa and GarsC201R alleles
All mice were identified by genotyping for the presence of the
human SOD1 transgene array, and/or the Dync1h1Loa/+ mutation
and/or the GarsC201R mutation. SOD1G93A genotyping is as
described previously [26] as is Dync1h1Loa genotyping [22]. The
GarsC201R mutation introduces a restriction site for the enzymes
HaeII and HhaI, allowing us to genotype by PCR followed by
RFLP analysis. GarsC201R PCR primers (forward:
CACGTGCTTGCTCTAGCAAGA; reverse: GTCTACCACT-
GAACACAGTCC) lying within intron 4 and intron 5 respective-
ly, (spanning exon 5 of Gars) were used to amplify a 420 bp
product. This amplicon is digested with HhaI to give fragments of
420 bp (no restriction site, wildtype Gars) and of 250 bp and
170 bp (GarsC201R mutant allele) [25].
Grip strength testing
The grip strength test assessed neuromuscular function by
measuring, with an electronic digital force gauge, the peak amount
of force an animal applied in grasping a 10 cm68 cm wire grid
attached to a pull bar (Bioseb Instruments). The mouse was placed
on the flat wire grid connected to the force gauge and held on with
front and hind paws. It was held by the base of the tail and was
gently pulled away from the grid until the mouse released its grip
at which point peak tension on the pull bar was recorded. The
mean of 5 measurements was determined for each mouse on each
day of testing and the result normalized by weight. Further details
of the Standard Operating Procedure for grip strength that we
followed can be found at the Eumorphia site http://www.
eumorphia.org/EMPReSS/servlet/EMPReSS.Frameset.
Mouse wire walk test
Wildtype, Dync1h1Loa/+ heterozygous, GarsC201R/+ heterozygous
and GarsC201R/+; Dync1h1Loa/+ double heterozygous littermates,
were tested at 7 months of age. Each animal was timed for one
minute as it walked on the wire grid top of the cage, which has
square holes (formed by the intercrossing wires) of 9 mm680 mm.
Mice were scored for every occasion in which they placed their
foot in the hole rather than on a wire (‘foot placing error’).
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Assessment of muscle force and motor unit number
The maximum twitch and tetanic force of the tibialis anterior
(TA) and extensor digitorum longus (EDL) muscles were assessed
in littermates at either 120 days of age (SOD1G93AxGarsC201R/+
cross) or 9 months of age (Dync1h1Loa/+ x GarsC201R/+ cross) as
described in Kieran et al, 2005.
The animals were anaesthetized (4.5% chloral hydrate solution,
1 ml/100 g body weight, i.p.; Sigma-Aldrich, Poole, UK) and
prepared for isometric tension recordings of muscle contraction
[42]. The distal tendons of the TA and EDL muscles were
exposed, dissected free from surrounding tissue and cut. The hind
limbs of the animals were then rigidly secured to the table with
stainless steel pins, and the distal tendons of the TA and EDL
muscles attached to an isometric force transducer (Dynamometer
UFI Devices) via silk thread. The sciatic nerve was exposed and
sectioned, and all branches cut except for the deep peroneal nerve
that innervates the TA and EDL muscles. The length of the
muscles was adjusted for maximum twitch tension. The muscles
and nerves were kept moist with saline throughout the recordings
and all experiments were carried out at room temperature (23uC).
Isometric contractions were elicited by stimulating the nerve to TA
and EDL using square-wave pulses of 0.02-ms duration and
supramaximal intensity via platinum electrodes. Tetanic contrac-
tions were elicited by trains of stimuli at a frequency of 40, 80, and
100 Hz. Maximum twitch and tetanic tension, time to peak, and
half-relaxation time values were measured using a computer and
appropriate software (Scope). The number of motor units in both
EDL muscles was assessed by applying stimuli of increasing
intensity to the motor nerve, resulting in stepwise increments in
twitch tension, due to successive recruitment of motor axons. The
number of stepwise increments was counted to give an estimate of
the number of functional motor units present in each muscle.
Fatigue test. At the end of the isometric tension recordings,
the fatigue pattern of the EDL muscles was assessed by repeatedly
stimulating the muscle at 40 Hz for 250 ms every second for
3 mins, and the contractions were recorded on a pen recorder
(Lectromed multitrace 2, UK Ltd). EDL is normally a fast
fatiguable muscle that fatigues rapidly when repeatedly stimulated.
From each fatigue trace, the decrease in tension after 3 min of
stimulation was measured and a fatigue index (F.I.) was calculated:
(initial tetanic tension – tetanic tension after stimulation)/initial
tetanic tension.
Muscle weight, histochemistry and morphometry. At
the end of each in vivo physiology experiment, the tibialis anterior
(TA) and extensor digitorum longus (EDL) muscles (C57BL/6
background) were removed, weighed, and snap frozen in
isopentane cooled in liquid nitrogen and stored at 280uC until
processing. Serial cross sections (10 mm) of TA muscles were cut
on a cryostat and stained for succinate dehydrogenase (SDH)
activity to determine the oxidative capacity of the muscle fibers, as
described previously [42]. The muscle sections were examined
under a light microscope (Leica DMR) using Leica HC PL Fluotar
objectives (106, 206and 406magnification). The cross-sectional
areas of the muscle fibers of from animals of each genotype were
calculated from SDH-stained muscle sections using three sections
from the belly of TA muscles from each mouse (n = 3). For each
muscle section, the cross-sectional areas (CSA) of ,2000 (+/287)
muscle fibers (approximately 70% of the TA muscle) were
calculated by tracing around the fiber perimeters using Leica
software. The analysis of CSA of muscle fibers is more accurate in
exposing changes in fiber size than measuring other parameters
such as muscle fiber diameter (Gorio et al., 1983).
Motor neuron survival. Following removal of the hindlimb
muscles the mice were perfused transcardially with 4% PFA in
0.1 M phosphate buffer saline. The lumbar region of the spinal
cord was removed, post-fixed in 4% PFA for 6 hours and
cryoprotected in 30% sucrose for a minimum of 8 hours. Serial
transverse sections (20 mm) were cut using a cryostat and stained
with gallocyanin, a Nissl stain. Spinal cord sections were examined
under a light microscope (Leica DMR) using Leica HC PL Fluotar
objectives (106, 206 and 406 magnification). The number of
Nissl-stained motor neurons in the sciatic motor pool of every third
section (n= 60) between the L2 and L5 levels of the spinal cord
were counted. Only large (diameter.12 mm), polygonal neurons
with a distinguishable nucleus and nucleolus and clearly
identifiable Nissl structure were included in the counts. Images
were captured using a Nikon E995 digital camera and the images
downloaded into Adobe Photoshop CS. To optimise image
contrast, Levels Adjustment operations were performed, but no
other image manipulations were made.
Statistical analysis for muscle and motor neuron
studies. Statistical significance among the groups was assessed
using a Mann-Whitney U test, student t-test and ANOVA.
Significance was set at P,0.05
Western hybridization and protein quantification
Mice were killed according to UK Home Office regulations and
brains and spinal cords were removed and flash frozen in liquid
nitrogen. Tissue was homogenized in PBS with protease inhibitors
(10% w/v) and the homogenate centrifuged for 20 min at
12,000 rpm at 4uC on a Beckman Coulter Allegra 25R centrifuge
(TS-5.1–500 rotor) to remove cellular debris. The protein
concentration of each sample was determined using a bicincho-
ninic acid assay (Pierce). Homogenates were electrophoresed on
Polyacrylamide–Tris gels (16% or 4–20% gradient) and then
transferred on to PVDF membrane (ImmobilonP). Membranes
were washed for 1 hour in blocking solution (5% w/v skim milk
powder, 0.05% Tween 20 in PBS), before addition of the primary
antibody in blocking solution at 4uC overnight. The primary
antibody was detected using AP conjugated anti-rabbit (Sigma)
and the results visualised using CPD-Star (Roche). The blots were
then stripped and reprobed using an antibody against b-actin
(Sigma A5441). Autoradiographs were quantified using Image-
master 1D software (Amersham Pharmacia Biotech) and the
protein levels normalised for b-actin levels.
Immunoprecipitation
Tissue homogenates were prepared according to the western
hybridization protocol described above. Trublot anti-rabbit or
anti-mouse Ig IP beads (eBioscience) were added to the
homogenate and the suspension incubated for 1 hour at 4uC on
a rotating shaker. The suspension was centrifuged to remove the
beads and the primary antibody and fresh beads were added to the
homogenate. The samples were incubated overnight at 4uC on a
rotating shaker. The beads were then collected by centrifugation
and washed three times in PBS with protease inhibitors and once
in PBS with 0.05% Tween 20. The beads were collected by
centrifugation and bound proteins removed by the addition of
SDS loading buffer. Samples were analyzed by western blotting in
accordance to the protocol above.
Antibodies
The following antibodies were used in western blotting and
immunoprecipitation protocols above: rabbit anti-GARS ([25]
from Dr. Kevin Talbot); mouse anti-SOD1 (Novocastra); mouse
anti-cytoplasmic dynein intermediate chain (Chemicon interna-
tional); rabbit anti-dynein light chain LC8 (Abcam); goat anti-
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mouse IgG and goat anti-rabbit IgG alkaline phosphatase
conjugated secondary antibodies (Sigma).
Statistical analysis for muscle and motor neuron studies
Statistical significance among the groups was assessed using a
Mann-Whitney U test, student t-test and ANOVA. Significance
was set at P,0.05
Supporting Information
Figure S1 EDL Muscle force in littermates from the
SOD1G93A x GarsC201R/+ cross at 120 days of age. The bar
charts show (A) the maximum twitch force and (B) maximum
tetanic force generated by EDL muscles in littermates of each
genotype. n= 5 female littermates per genotype. See Supplemen-
tary Table 1 for data. Error bars represent SEM.
Found at: doi:10.1371/journal.pone.0006218.s001 (0.17 MB TIF)
Figure S2 GARS protein levels in SOD1G93A x GarsC201R/+ and
Dync1h1Loa/+ x GarsC201R/+ crosses at 4 months of age. (A)
Representative western blot of GARS using spinal cord homog-
enates from progeny of the SOD1G93A x GarsC201R/+ cross. b-actin
blots are shown as loading controls. (B) Quantification of GARS
protein levels in the progeny of the SOD1G93A x GarsC201R/+ cross
show a significant increase in GARS levels in GarsC201R/+ and
SOD1G93A;GarsC201R/+ animals. Quantifications were normalized
to b-actin. (C) Representative western blot of GARS using spinal
cord homogenates from progeny of the Dync1h1Loa/+ x GarsC201R/+
cross. b-actin blots are shown as loading controls. (D) Quantifi-
cation of GARS protein levels in the progeny of the Dync1h1Loa/+ x
GarsC201R/+ cross show a significant increase in GARS levels in
GarsC201R/+ and Dync1h1Loa/+;GarsC201R/+ animals. Quantifications
were normalized to b-actin.
Found at: doi:10.1371/journal.pone.0006218.s002 (0.38 MB TIF)
Figure S3 Four paw grip strength of sex-matched wildtype,
Dync1h1Loa/+, GarsC201R/+, and Dync1h1Loa/+;GarsC201R/+ littermates
at 7 months of age, normalized by weight.
Found at: doi:10.1371/journal.pone.0006218.s003 (0.23 MB TIF)
Figure S4 TA and EDL muscle weight and force and EDL
motor unit survival and fatigue characterstics in littermates from
the Dync1h1Loa/+ x GarsC201R/+ cross at 120 days of age. The bar
charts show (A) the mean TA muscle weight and (B) the maximum
tetanic force of TA; (C) the mean EDL muscle weight and (D)
maximum tetanic force of EDL; (E) the mean number of motor
units in the EDL muscle and (F) the mean fatigue index of EDL
muscles. An FI approaching 1 indicates that the muscle is highly
fatiguable. N= 3 for all genotypes; error bars are S.E.M
Found at: doi:10.1371/journal.pone.0006218.s004 (0.48 MB
DOC)
Table S1 Mean muscle force and weight of EDL muscles of
littermates from the SOD1G93A x GarsC201R/+ cross at 120
days of age.
Found at: doi:10.1371/journal.pone.0006218.s005 (0.03 MB
DOC)
Table S2 Contractile and fatigue characteristics of EDL muscles of
littermates from the SOD1G93A x GarsC201R/+ cross at 120 days of age
Found at: doi:10.1371/journal.pone.0006218.s006 (0.03 MB
DOC)
Table S3 Mean muscle force and weight of TA and EDL
muscles of littermates from the Dync1h1Loa/+ x GarsC201R/+ cross at
9 months of age.
Found at: doi:10.1371/journal.pone.0006218.s007 (0.03 MB
DOC)
Movie S1 Littermates from the Dync1h1Loa/+ x GarsC201R/+ cross
at 6 months of age. Wildtype littermate.
Found at: doi:10.1371/journal.pone.0006218.s008 (21.47 MB
MPG)
Movie S2 Littermates from the Dync1h1Loa/+ x GarsC201R/+ cross
at 6 months of age. Dync1h1Loa/+ littermate.
Found at: doi:10.1371/journal.pone.0006218.s009 (47.66 MB
MPG)
Movie S3 Littermates from the Dync1h1Loa/+ x GarsC201R/+ cross
at 6 months of age. GarsC201R/+ littermate.
Found at: doi:10.1371/journal.pone.0006218.s010 (47.05 MB
MPG)
Movie S4 Littermates from the Dync1h1Loa/+ x GarsC201R/+ cross
at 6 months of age. Dync1h1Loa/+;GarsC201R/+ double heterozygote
littermate.
Found at: doi:10.1371/journal.pone.0006218.s011 (48.04 MB
MPG)
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